TLDR The combined Selencin treatment effectively reduces hair loss and improves hair health after COVID-19.
The study investigated the effectiveness of a combination treatment using Selencin (a homeopathic drug) and Selencin Peptide Active (a peptide lotion) for diffuse alopecia (DA) associated with prior COVID-19 infection. Involving 34 patients with confirmed telogen/anagen DA linked to COVID-19, the treatment was administered both systemically and topically over 2 months. Results indicated a significant reduction in hair loss, restoration of hair structure, and increased volume. Additionally, improvements were observed in scalp dermatoscopic images and PULL test results after 2 and 4 months. The study concluded that the combined Selencin treatment had a pronounced therapeutic effect and could serve as a primary treatment for COVID-19-associated DA.
7 citations
,
December 2020 in “Clinics in Dermatology” Some alopecia treatments might help treat COVID-19, but more research is needed.
10 citations
,
June 2015 in “Seminars in cutaneous medicine and surgery” Hair loss can be caused by various factors, and treatments focus on restoring normal hair growth.
70 citations
,
January 2015 in “Journal of Clinical and Diagnostic Research” Hair loss from Telogen Effluvium usually gets better within 6 months after addressing the cause.
1 citations
,
August 2022 in “JAAD case reports” Tofacitinib and oral minoxidil may help treat Sisaipho alopecia areata.
5 citations
,
January 2020 in “Journal of Dermatology” Temporal hair loss relates to overall scalp hair loss in women.
24 citations
,
November 2013 in “Trends in pharmacological sciences” Increasing ABC transporters in hair follicles may prevent chemotherapy-induced hair loss.
218 citations
,
January 2013 in “The Lancet Oncology” Chemotherapy causes hair loss by damaging hair follicles and stem cells, with more research needed for prevention and treatment.
41 citations
,
December 2008 in “International Journal of Dermatology” South Korean women with hair loss have lower hair density and thickness compared to healthy women.
236 citations
,
July 2001 in “Trends in Molecular Medicine” Future hair loss treatments should aim to extend hair growth, reactivate resting follicles, reverse shrinkage, and possibly create new follicles, with gene therapy showing promise.
